Director Dealing

RNS Number : 5334U

Abingdon Health PLC

06 April 2021

 

Director Dealing

York, U.K. 6^th April 2021:   Abingdon Health (AIM:ABDX) ("Abingdon" or "the Company"), a leading international developer and manufacturer of high quality and effective rapid tests, announces that Melanie Ross, Chief Financial Officer, has today purchased 5,338 ordinary shares of 0.025p each in the Company ("Ordinary Shares") at a price of 93.45 pence per Ordinary Share. Prior to this, Melanie did not hold an interest in any Ordinary Shares, and therefore has a resultant interest in 0.01% of the Company's issued share capital.

- Ends-

Enquiries:

Abingdon Health plc
Chris Yates		Chief Executive Officer		Via Consilium
Melanie Ross		Chief Financial Officer
Chris Hand		Non-Executive Chairman
N+1 Singer		Sole Broker and Nominated Adviser
Shaun Dobson, Peter Steel,				Tel: [phone]
Alex Bond (Corporate Finance)
Tom Salvesen (Corporate Broking)
Consilium		Financial PR		Tel: [phone]
Matthew Neal		[e-mail]
Mary-Jane Elliott
Lindsey Neville

About Abingdon Health

Abingdon Health is a world leading developer and manufacturer of high-quality rapid tests across all industry sectors, including healthcare and COVID-19. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and has also developed and marketed its own labelled tests.

The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx^®, a customisable image capturing technology that transforms a smartphone into a self-sufficient, standalone lateral-flow reader.

Founded in 2008, Abingdon Health is headquartered in York, England.

https://www.abingdonhealth.com/

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Melanie Ross
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Abingdon Health plc
b)	LEI	213800XFI4WV3FBILO20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of 0.025 pence each
	Identification code	GB00BLF79J41
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			93.45 pence	5,338
d)	Aggregated information	N/A single transaction
	- Aggregated volume
	- Price
e)	Date of the transaction	6 April 2021
f)	Place of the transaction	London Stock Exchange

 

END

 

 

DSHBDGDSBXGDGBL